PEDIATRIC CRITICAL CARE DEPARTMENT OF UNIVERSITY OF UTAH

100 N MARIO CAPECCHI DR

Articles

Review Links PFAS to Nonalcoholic Fatty Liver Disease

May 03, 2022

Evaluation of 111 studies showed a link between the endocrine-disrupting chemicals and elevated levels of alanine aminotransferase, a liver enzyme elevated in people with nonalcoholic fatty liver disease.

Pharma Exec Details Hepatitis B Progress, New HBV

April 01, 2022

VBI Vaccines’s PreHevbrio [Hepatitis B Vaccine (Recombinant)], the only approved 3-antigen hepatitis B vaccine for adults, is now commercially available in the U.S. after approval by the FDA late last year.

MS Patients Warmed To Telehealth During the COVID-19 Pandemic

March 08, 2022

Analysis of answers to online survey shows that telehealth use is high among people with multiple sclerosis (MS) amid the COVID-19 pandemic. Telehealth may be an appealing option for patients with MS who have physical impairments that make traveling to in-person appointments difficult.

New VCU Institute Aims to Transform Treatment of Liver Disease Care

March 02, 2022

One of the priorities of the new institute at Virginia Commonwealth University’s medical school will be research into nonalcoholic steatohepatitis (NASH) as a key component in the emerging construct of metabolic health, says its leader, Arun J. Sanyal, M.D.